galactose has been researched along with bay 63-2521 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, X; Cheng, Z; Li, C; Li, F; Nie, G; Qi, F; Sun, J; Wu, Z; Zhao, Y | 1 |
1 other study(ies) available for galactose and bay 63-2521
| Article | Year |
|---|---|
The Combination of Sinusoidal Perfusion Enhancement and Apoptosis Inhibition by Riociguat Plus a Galactose-PEGylated Bilirubin Multiplexing Nanomedicine Ameliorates Liver Fibrosis Progression.
Topics: Animals; Apoptosis; Bilirubin; Galactose; Liver; Liver Cirrhosis; Mice; Nanomedicine; Perfusion; Polyethylene Glycols; Reactive Oxygen Species | 2023 |